Biotricity Inc. received more than $240,000 in a grant from the U.S. National Heart, Blood and Lung Institute of the National Institutes of Health to launch a study of a new algorithm to be used with its Bioflux device to assess the risk of stroke in patients with chronic kidney disease (CKD).
Carbon Medtech (Shenzhen) Co. Ltd. reported that it has raised “tens of millions of yuan” from its pre-A+ round financing. This financing was jointly led by Jinding Capital and Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group Co. Ltd.
Startup Curimeta Inc. emerged from stealth with $6 million in seed financing led by Washington University School of Medicine in St. Louis and BJC Healthcare, a St. Louis-based nonprofit health care system. Cultivation Capital Healthcare Innovation Fund also participated in the round.
Shanghai Microport Ep Medtech Co. Ltd. went public on the Shanghai Stock Exchange STAR Market and raised ¥1.17 billion (US$169.5 million) with its initial public offering. The company’s issue price was ¥16.51 per share. After opening at ¥15.50 per share, the share price dived to ¥13.15 at the closing of its first trading day. Microport Ep is an associated company of the Hong Kong-listed Microport Scientific Corp.
The University of Sydney is investing AU$478 million (US$326.5 million) to build a leading biomedical precinct to fast-track research and shorten the time between discovery and development of transformative therapies.
Sichuan Jinjiang Electronic Science and Technology Co. Ltd. (JJET) recently completed series A+ and series B rounds, raising a total of ¥700 million (US$101 million) in series A and series B financing.
RSS
